SHEHNAAZ SULIMAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SHEHNAAZ SULIMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SHEHNAAZ SULIMAN. SHEHNAAZ SULIMAN is a Director in Ultragenyx Pharmaceutical Inc. ($RARE) and a SVP, Corp Dev & Strategy in Theravance Biopharma, Inc. ($TBPH) and a President and COO in Alector, Inc. ($ALEC) and a Director in 10x Genomics, Inc. ($TXG).
Address: C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO 94080 CA
Companies in which SHEHNAAZ SULIMAN is an Insider
10x Genomics, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of SHEHNAAZ SULIMAN: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Alector, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SHEHNAAZ SULIMAN: President and COO
Holdings: 0 shares
Latest Transaction: Oct 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SHEHNAAZ SULIMAN: SVP, Corp Dev & Strategy
Holdings: 97,198 shares
Current Value: $2,974,259
Latest Transaction: Feb 22 2019
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SHEHNAAZ SULIMAN: Director
Holdings: 5,550 shares
Current Value: $404,651
Latest Transaction: Jun 30 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SHEHNAAZ SULIMAN
Sentiment: All, TXG, ALEC, TBPH, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2020 | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | President and COO | Option Exercise | A | 10.24 | 189,213 | 1,937,541 | 189,213 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Grant | A | 0.00 | 2,550 | 0 | 5,550 | 3 K to 5.6 K (+85.00 %) |
| Jun 17 2020 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
| Jan 27 2020 | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | President and COO | Option Exercise | A | 17.23 | 550,000 | 9,476,500 | 550,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | J | 30.00 | 100,000 | 3,000,000 | 100,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | J | 30.00 | 100,000 | 3,000,000 | 0 |